Corrigendum to ‘Intradiscal linezolid (PP353) treatment for chronic low back pain associated with Modic change type 1: an international, first-in-human, randomised, sham procedure-controlled, double-blind, phase 1b clinical trial’ eClinicalMedicine 2026; 92: 103764

EClinicalMedicine 2026 Open access

Read full text
Authors: Michael Rud Lassen, Matthew Scarborough, Nigel Leslie Gilchrist, Shiva Shankar Tripathi, Cathy Price, A. Horcajadas, Javier DeAndres, Ganesan Baranidharan, Sashin Ahuja, Kristian Stahl Otte, Emily A. Wood, Sarah Guest
+2 more Lloyd G. Czaplewski, Duncan McHale
DOI: 10.1016/j.eclinm.2026.103834
Cited by: 0

Abstract

In this Article, due to copy and paste errors, the legends for Figure 3, and Figures S1 and S2 in the appendix, contained errors, which might lead to confusion regarding which statistical tests were used. The original legends contained the following phrases:

Fields of Study & Subjects

Spine and Intervertebral Disc Pathology Musculoskeletal pain and rehabilitation Pain Mechanisms and Treatments

Publication details

Journal / source
EClinicalMedicine
Volume
93
Pages
103834–103834
Publication date
1 March 2026
Language
EN